Skip to main content
Top
Published in: AIDS and Behavior 3/2014

01-03-2014 | Original Paper

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City

Authors: D. C. Des Jarlais, K. Arasteh, C. Mcknight, J. Feelemyer, H. Hagan, H. L. F. Cooper, D. C. Perlman

Published in: AIDS and Behavior | Issue 3/2014

Login to get access

Abstract

Examine long term sexual risk behaviors among persons who inject drugs (PWID) in New York City following implementation of “combined” prevention programming, including condom social marketing. Quantitative interviews and human immunodeficiency virus (HIV) testing were conducted among PWID entering Beth Israel Medical Center drug treatment programs 1990–2012. Data were analyzed by four time periods corresponding to the cumulative implementation of HIV prevention interventions. 7,132 subjects were recruited from 1990 to 2012; little change in sexual behavior occurred among HIV seronegative subjects, while HIV seropositive subjects reported significant decreases in being sexually active and significant increases in consistent condom use. HIV transmission risk (being HIV positive and engaging in unprotected sex) declined from 14 % in 1990–1995 to 2 % in 2007–2012 for primary sexual partners and from 6 to 1 % for casual partners. Cumulative implementation of combined prevention programming for PWID was associated with substantial decreases in sexual risk behavior among HIV seropositives.
Literature
1.
go back to reference World Health Organization UNODC, Joint United Nations Programme on HIV/AIDS. Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: 2008. World Health Organization UNODC, Joint United Nations Programme on HIV/AIDS. Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: 2008.
2.
go back to reference Sendziuk P. Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison. Can Bull Med Hist/Bulletin canadien d’histoire de la médecine. 2007;24(1):113–29. Sendziuk P. Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison. Can Bull Med Hist/Bulletin canadien d’histoire de la médecine. 2007;24(1):113–29.
3.
go back to reference Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376(9737):285–301.PubMedCrossRef Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376(9737):285–301.PubMedCrossRef
4.
go back to reference Van den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102(9):1454–62.CrossRef Van den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102(9):1454–62.CrossRef
5.
go back to reference de Vos AS, van der Helm JJ, Prins M, Kretzschmar MEE. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam: evidence for harm reduction? Paper presented at: International AIDS Conference 2012; Washington D.C. de Vos AS, van der Helm JJ, Prins M, Kretzschmar MEE. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam: evidence for harm reduction? Paper presented at: International AIDS Conference 2012; Washington D.C.
6.
go back to reference Des Jarlais DC, Arasteh K, McKnight C, et al. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend. 2010;109(1):154–60.PubMedCrossRef Des Jarlais DC, Arasteh K, McKnight C, et al. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend. 2010;109(1):154–60.PubMedCrossRef
7.
go back to reference Montaner J, Lima VD, Yip B, Day I, et al. Expanded HAART coverage is associated with decreased HIV/AIDS morbidity and HIV new diagnoses: an update on the ‘treatment as prevention’ experience in British Columbia, Canada. Paper presented at: International AIDS Conference 2012; Washington D.C. Montaner J, Lima VD, Yip B, Day I, et al. Expanded HAART coverage is associated with decreased HIV/AIDS morbidity and HIV new diagnoses: an update on the ‘treatment as prevention’ experience in British Columbia, Canada. Paper presented at: International AIDS Conference 2012; Washington D.C.
8.
go back to reference Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRef Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRef
9.
go back to reference Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(4):iii7–14.PubMedCentralPubMed Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(4):iii7–14.PubMedCentralPubMed
10.
go back to reference Des Jarlais DC, Arasteh K, McKnight C, et al. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend. 2010;109(1–3):154–60.PubMedCrossRef Des Jarlais DC, Arasteh K, McKnight C, et al. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend. 2010;109(1–3):154–60.PubMedCrossRef
11.
go back to reference Newman RG, Cates MS. Methadone treatment in narcotic addiction: program management, findings, and prospects for the future. New York: Academic Press; 1977. Newman RG, Cates MS. Methadone treatment in narcotic addiction: program management, findings, and prospects for the future. New York: Academic Press; 1977.
12.
go back to reference Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95(8):1439–44.PubMedCentralPubMedCrossRef Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95(8):1439–44.PubMedCentralPubMedCrossRef
13.
go back to reference Heller D, Paone D. Access to sterile syringes for injecting drug users in New York City: politics and perception (1984–2010). Subst Use Misuse. 2011;46(2–3):140–9.PubMedCrossRef Heller D, Paone D. Access to sterile syringes for injecting drug users in New York City: politics and perception (1984–2010). Subst Use Misuse. 2011;46(2–3):140–9.PubMedCrossRef
14.
go back to reference Des Jarlais DC, Arasteh K, Friedman SR. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst Use Misuse. 2011;46(2–3):131–9.PubMedCrossRef Des Jarlais DC, Arasteh K, Friedman SR. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst Use Misuse. 2011;46(2–3):131–9.PubMedCrossRef
15.
go back to reference Henman AR, Paone D, Des Jarlais DC, Kochems LM, Friedman SR. Injection drug users as social actors: a stigmatized community’s participation in the syringe exchange programmes of New York City. AIDS Care. 1998;10(4):397–408.PubMedCrossRef Henman AR, Paone D, Des Jarlais DC, Kochems LM, Friedman SR. Injection drug users as social actors: a stigmatized community’s participation in the syringe exchange programmes of New York City. AIDS Care. 1998;10(4):397–408.PubMedCrossRef
16.
go back to reference Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007;97(1):117–24.PubMedCentralPubMedCrossRef Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007;97(1):117–24.PubMedCentralPubMedCrossRef
17.
go back to reference Deren S, Hagan H, Friedman S, et al. Current and emerging research needs in studying the NYC HIV-drug use epidemic. Subst Use Misuse. 2011;46(2–3):316–9.PubMedCrossRef Deren S, Hagan H, Friedman S, et al. Current and emerging research needs in studying the NYC HIV-drug use epidemic. Subst Use Misuse. 2011;46(2–3):316–9.PubMedCrossRef
18.
go back to reference Lert F, Kazatchkine MD. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview. Int J Drug Policy. 2007;18(4):255–61.PubMedCentralPubMedCrossRef Lert F, Kazatchkine MD. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview. Int J Drug Policy. 2007;18(4):255–61.PubMedCentralPubMedCrossRef
19.
go back to reference New York City Department of Health and Mental Hygiene. HIV Surveillance & Epidemiology Program—HIV/AIDS Annual Surveillance Statistics. New York City: NYCDOHMH;1982–2013. New York City Department of Health and Mental Hygiene. HIV Surveillance & Epidemiology Program—HIV/AIDS Annual Surveillance Statistics. New York City: NYCDOHMH;1982–2013.
20.
go back to reference Chiasson MA, Berenson L, Li W, et al. Declining HIV/AIDS mortality in New York city. JAIDS. 1999;21(1):59–64.PubMed Chiasson MA, Berenson L, Li W, et al. Declining HIV/AIDS mortality in New York city. JAIDS. 1999;21(1):59–64.PubMed
21.
go back to reference Messeri P, Lee G, Abramson DM, Aidala A, Chiasson MA, Jessop DJ. Antiretroviral therapy and declining AIDS mortality in New York City. Med Care. 2003;41(4):512–21.PubMed Messeri P, Lee G, Abramson DM, Aidala A, Chiasson MA, Jessop DJ. Antiretroviral therapy and declining AIDS mortality in New York City. Med Care. 2003;41(4):512–21.PubMed
22.
go back to reference Wong T, Chiasson M, Reggy A, Simonds R, Heffess J, Loo V. Antiretroviral therapy and declining AIDS mortality in New York City. J Urban Health. 2000;77:492–500.PubMedCentralPubMedCrossRef Wong T, Chiasson M, Reggy A, Simonds R, Heffess J, Loo V. Antiretroviral therapy and declining AIDS mortality in New York City. J Urban Health. 2000;77:492–500.PubMedCentralPubMedCrossRef
23.
go back to reference Burke RC, Wilson J, Bernstein KT, et al. The NYC Condom: use and acceptability of New York City’s branded condom. Am J Public Health. 2009;99(12):2178–80.PubMedCentralPubMedCrossRef Burke RC, Wilson J, Bernstein KT, et al. The NYC Condom: use and acceptability of New York City’s branded condom. Am J Public Health. 2009;99(12):2178–80.PubMedCentralPubMedCrossRef
24.
go back to reference Burke RC, Wilson J, Kowalski A, et al. NYC Condom use and satisfaction and demand for alternative condom products in New York City sexually transmitted disease clinics. J Urban Health. 2011;88(4):749–58.PubMedCentralPubMedCrossRef Burke RC, Wilson J, Kowalski A, et al. NYC Condom use and satisfaction and demand for alternative condom products in New York City sexually transmitted disease clinics. J Urban Health. 2011;88(4):749–58.PubMedCentralPubMedCrossRef
25.
go back to reference Des Jarlais DC, McKnight CM, Arasteh K, et al. Use of the “NYC Condom” among people who use drugs. J Urban Health. (in press). Des Jarlais DC, McKnight CM, Arasteh K, et al. Use of the “NYC Condom” among people who use drugs. J Urban Health. (in press).
26.
go back to reference Des Jarlais DC, Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261(7):1008–12.PubMedCrossRef Des Jarlais DC, Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261(7):1008–12.PubMedCrossRef
27.
go back to reference Des Jarlais DC, Arasteh K, Hagan H, McKnight C, Perlman DC, Friedman SR. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health. 2009;99(S2):S445–51.PubMedCrossRef Des Jarlais DC, Arasteh K, Hagan H, McKnight C, Perlman DC, Friedman SR. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health. 2009;99(S2):S445–51.PubMedCrossRef
28.
go back to reference Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS. 2005;19:S20–5.PubMedCrossRef Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS. 2005;19:S20–5.PubMedCrossRef
29.
go back to reference Stata 12 [computer program]. College Station, Texas 2012. Stata 12 [computer program]. College Station, Texas 2012.
30.
go back to reference Des Jarlais DC, Bramson HA, Wong C, et al. Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction. 2012;107(12):2087–95.PubMedCentralPubMedCrossRef Des Jarlais DC, Bramson HA, Wong C, et al. Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction. 2012;107(12):2087–95.PubMedCentralPubMedCrossRef
31.
go back to reference Parsons JT, Schrimshaw EW, Wolitski RJ, et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS. 2005;19:S13–25.PubMedCrossRef Parsons JT, Schrimshaw EW, Wolitski RJ, et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS. 2005;19:S13–25.PubMedCrossRef
32.
go back to reference MacKellar DA, Hou SI, Whalen CC, et al. HIV/AIDS complacency and HIV infection among young men who have sex with men, and the race-specific influence of underlying HAART beliefs. Sex Transm Dis. 2011;38(8):755–63.PubMed MacKellar DA, Hou SI, Whalen CC, et al. HIV/AIDS complacency and HIV infection among young men who have sex with men, and the race-specific influence of underlying HAART beliefs. Sex Transm Dis. 2011;38(8):755–63.PubMed
33.
go back to reference Des Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health. 1998;88(12):1801–6.PubMedCentralPubMedCrossRef Des Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health. 1998;88(12):1801–6.PubMedCentralPubMedCrossRef
34.
go back to reference Des Jarlais DC, Perlis T, Arasteh K, et al. “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. JAIDS. 2004;35(2):158–66.PubMed Des Jarlais DC, Perlis T, Arasteh K, et al. “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. JAIDS. 2004;35(2):158–66.PubMed
Metadata
Title
Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City
Authors
D. C. Des Jarlais
K. Arasteh
C. Mcknight
J. Feelemyer
H. Hagan
H. L. F. Cooper
D. C. Perlman
Publication date
01-03-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0664-0

Other articles of this Issue 3/2014

AIDS and Behavior 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.